Fulgent Genetics, Inc. FLGT Noncontrolling interests in subsidiaries
Noncontrolling interests in subsidiaries at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s noncontrolling interests in subsidiaries.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s noncontrolling interests in subsidiaries?
- Fulgent Genetics, Inc. (FLGT) reported noncontrolling interests in subsidiaries of -$5.66M in Q1 2026.
- How has Fulgent Genetics, Inc.'s noncontrolling interests in subsidiaries changed year-over-year?
- Fulgent Genetics, Inc.'s noncontrolling interests in subsidiaries decreased by 28.3% year-over-year, from -$4.41M to -$5.66M.
- What is the long-term trend for Fulgent Genetics, Inc.'s noncontrolling interests in subsidiaries?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s noncontrolling interests in subsidiaries has grown at a -7.3% compound annual growth rate (CAGR), from $7.13M to -$5.27M.
- What does noncontrolling interests in subsidiaries mean?
- This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.